Endocrine And Metabolic Consequences Of Childhood Obesity Volume Ii

This issue of Endocrinology and Metabolism Clinics will cover Obesity. Curated by Dr. Michael D. Jensen, this issue will explore topics in the field that are relevant for practicing clinicians. This issue is one of four selected each year by the series Consulting Editor, Adriana G. Ioachimescu. The volume will include articles on: The role of the environment in the “obesity epidemic, Endoscopic treatments for obesity, Visceral fat, Role of commercial weight loss programs in medical management of obesity, Racial differences in metabolic consequences of fat gain, Sex differences in adipose tissue function, Common and rare complications of bariatric surgery, Strategies for physical activity interventions in the treatment of obesity, Effects of pregnancy on childhood overweight and obesity, Iatrogenic Obesity, Growth hormone and obesity, and Barriers and solutions for prescribing obesity pharmacotherapy.

This volume includes the latest diagnostic criteria for PCOS and comprises the most up-to-date information about the genetic features and pathogenesis of PCOS. It critically reviews the methodological approaches and the evidence for various PCOS susceptibility genes. The book also discusses additional familial phenotypes of PCOS and their potential genetic basis. All four editors of this title are extremely prominent in the field of PCOS.

This issue of Endocrinology and Metabolism Clinics will cover Obesity. Curated by Dr. Michael D. Jensen, this issue will explore topics in the field that are relevant for practicing clinicians. This issue is one of four selected each year by the series Consulting Editor, Adriana G. Ioachimescu. The volume will include articles on: The role of the environment in the "obesity epidemic, ? Endoscopic treatments for obesity, Visceral fat, Role of commercial weight loss programs in medical management of obesity, Racial differences in metabolic consequences of fat gain, Sex differences in adipose tissue function, Common and rare complications of bariatric surgery, Strategies for physical activity interventions in the treatment of obesity, Effects of pregnancy on childhood overweight and obesity, Iatrogenic Obesity, Growth hormone and obesity, and Barriers and solutions for prescribing obesity pharmacotherapy

Understanding the relationship between energy balance and obesity is essential to develop effective prevention programs and policies. The International Agency for Research on Cancer convened a Working Group of world-leading experts in December 2015 to review the evidence regarding energy balance and obesity, with a focus on low- and middle-income countries, and to consider the following scientific questions: (i) Are the drivers of the obesity epidemic related only to energy excess and/or do specific foods or nutrients play a major role in this epidemic? (ii) What are the factors that modulate these associations? (iii) Which types of data and/or studies will further improve our understanding? This book provides summaries of the evidence from the literature as well as the Working Group's conclusions and recommendations to tackle the global epidemic of obesity.

This book analyzes in detail all aspects related to endocrine and metabolic late effects observed in patients treated for cancer, both in childhood and adulthood. The chapters focusing on the possible pathogenic mechanisms of late effects (i.e., premature aging and chronic inflammation) and on bone health in cancer survivors are particularly interesting and innovative. The volume also deals with hypothalamic-pituitary, thyroid and gonadal disorders, including infertility and how to prevent it. Finally, the relationship between metabolic alterations and cardiovascular diseases in cancer survivors is addressed. Thanks to advances in cancer treatment and supportive care, the five-year survival rate of cancer patients is constantly increasing. However, this undisputable success of medicine has a flip side: the late adverse effects of anticancer therapies. Pediatric oncologists were the first to cope with late complications of treatments, but today also adult oncologists and onco-hematologists recognize the relevance of this issue. Even though late effects observed in cancer survivors can affect any organ or system, endocrine and metabolic dysfunctions are the most frequently reported. Endocrine complications rarely influence life expectancy of cancer survivors, but they can significantly impact morbidity and quality of life. Among endocrine adverse effects, severe hypothalamic damage may be considered the most harmful in survivors, leading to morbid obesity, propensity to metabolic syndrome and cardiovascular disease. This book aims to disseminate the knowledge about endocrine and metabolic adverse effects of cancer therapies and about survivorship care. Since the number of cancer survivors is steadily growing in the general population, this publication is intended not only for endocrinologists but also for oncologists, onco-hematologists, internists, pediatric specialists in those areas and general practitioners, with the aim to better counsel and monitor cancer survivors.

Now, in one comprehensive, easy-to-access volume, this essential handbook lays bare the scope of the growing problem of childhood and adolescent obesity. It goes further, too, examining the impact of the epidemic in terms of its psychological burden, its health consequences, and the available prevention and treatment options. Editors Jelalian and Steele have ensured that the chapters utilize the most up-to-date empirical and clinical knowledge available. This volume provides readers not only raw data, but also a framework for translating findings into effective, efficient practice – assessment, treatment, and prevention. It will be required reading for a host of professionals, from psychologists to social workers and medical practitioners.